loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 203699 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 PHARMADAX INC (2)

filter

01 TABLET, EXTENDED RELEASE;ORAL (2)

filter

01 RX (2)

filter

01 METOPROLOL SUCCINATE (2)

filter

01 No (2)

URL Supplier Web Content
TABLET, EXTENDED R...
EQ 100MG TARTRATE
2020-03-30
203699
METOPROLOL SUCCINA...
RX
No
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET, EXTENDED R...
EQ 200MG TARTRATE
2020-03-30
203699
METOPROLOL SUCCINA...
RX
No
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 203699

Looking for FDA Orange Book APPLICATION 203699 2

19

Pharmadax, based in Taiwan, is a pharmaceutical company.

One of their notable products is METOPROLOL SUCCINATE, with a corresponding application number 203699.

Regulatory Information RX

With a dosage strength EQ 100MG TARTRATE

Dosage Form Route TABLET, EXTENDED RELEASE; ORAL

Reference Listed Drug No

Approved since 2020-03-30

Therapeutic Equivalence (TE) Code AB

18

Pharmadax, based in Taiwan, is a pharmaceutical company.

One of their notable products is METOPROLOL SUCCINATE, with a corresponding application number 203699.

Regulatory Information RX

With a dosage strength EQ 200MG TARTRATE

Dosage Form Route TABLET, EXTENDED RELEASE; ORAL

Reference Listed Drug No

Approved since 2020-03-30

Therapeutic Equivalence (TE) Code AB

Post Enquiry
POST ENQUIRY